Author: Michelle Valderama

The IAS–USA celebrates the life and career of California Senator Dianne Feinstein, who passed away on Thursday, September 28, 2023. Feinstein was a champion for many progressive causes, including women's rights, LGBT+ rights, rational gun control legislation, access to health care, and an individual's right to control their bodies. Those of us who live in [...]

The IAS–USA is pleased to welcome guest discussant Katelyn K. Jetelina, MPH, PhD, epidemiologist, data scientist, and author of the popular Your Local Epidemiologist (YLE) newsletter. Dr Jetelina joins moderator Paul Volberding, MD, and discussants Peter Chin-Hong, MD, and Carlos del Rio, MD. IAS–USA Dialogues (formerly COVID-19 Dialogues) were created to address an urgent need for reliable scientific information, with understanding of […]

To comply with the MATE Act, all registered practitioners are now required by the Drug Enforcement Administration (DEA) to complete an 8-hour training session aimed at educating them on how to treat and manage patients who are dealing with substance use disorders. Each free webinar is eligible for 1.25 AMA PRA Category 1 Credits™ and 1.25 American […]

General abstract and scholarship submissions for the 31th Conference on Retroviruses and Opportunistic Infections (CROI) are now being accepted. The deadline to submit a general abstract and scholarship application is Wednesday, September 27, 2022, at 5:00 PM Pacific Time. Visit the Abstract Guidelines and Submission and Scholarships webpages for more information.

To comply with the MATE Act, all registered practitioners are now required by the Drug Enforcement Administration (DEA) to complete an 8-hour training session aimed at educating them on how to treat and manage patients who are dealing with substance use disorders. Each free webinar is eligible for 1.25 AMA PRA Category 1 Credits™ and 1.25 American […]

To comply with the MATE Act, all registered practitioners are now required by the Drug Enforcement Administration (DEA) to complete an 8-hour training session aimed at educating them on how to treat and manage patients who are dealing with substance use disorders. The first installment of our 6-part webinar series, (Part 1 of 6) Substance [...]

Respiratory syncytial virus (RSV) and influenza are viruses associated with high mortality in children. Children at risk include the very young (<2 years of age) and those with immunocompromising conditions, such as HIV. This webinar, led by Yvonne Maldonado, MD, and moderated by Carlos del Rio, MD, will discuss the latest science and recommendations for the […]

The webinar, Cardiovascular Disease Prevention in Patients With HIV: The REPRIEVE Trial, to be presented by Steven K. Grinspoon, MD, and currently scheduled for October 12, 2023, is being rescheduled for a later date. Unfortunately, we inadvertently scheduled this webinar during the IDWeek meeting and will need to reschedule. Once a new date is selected, […]

Presented by Michael S. Saag, MD, Melanie A. Thompson, MD, and Roger J. Bedimo, MD, MS, this webinar will describe the core principles of HIV management, including pathogenesis of HIV infection and mechanisms of action of antiretroviral drugs, as well as initiating antiretroviral therapy and primary care for people who are newly diagnosed with HIV. This […]

The primary results of the REPRIEVE Trial have been published and show that the statin drug pitavastatin calcium lowers the risk of heart disease in people with HIV by 35%. The results of this important large, randomized trial will have a substantial impact on the health of people with HIV.  Congratulations to the study team, led by IAS-USA Core Faculty member Dr Steven Grinspoon, for bringing these important results to the HIV community. The details and results [...]